← FDA DRUG APPROVALS

FDA ANDA · ANDA060869

OXYTETRACYCLINE HYDROCHLORIDE

Sponsor: PROTER

APPLICATION
ANDA060869
TYPE
ANDA
ORIGINAL APPROVAL
1964-01-29
LATEST ACTION
1964-01-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

OXYTETRACYCLINE HYDROCHLORIDEDiscontinued
OXYTETRACYCLINE HYDROCHLORIDE EQ 250MG BASE · CAPSULE · ORAL

Approval history

1964-01-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →